Precision medicine, the new era of treating early-stage breast cancer, brings a variety of individualized methods; not only does it raise the odds of success, but it also accommodates the distinct genetics and tumor traits of each patient. This is the latest branch of cancer healthcare that utilizes investigative tests and personalized profiling of patients to design custom treatment plans that are similar to patients.